Has John Mounsey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $70,093 in general payments to John Mounsey, MD across 158 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Mounsey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Mounsey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Mounsey, MD

Clinical Cardiac Electrophysiology · Charlottesville, VANPI 1235295908

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $52,175 of the $70,093 with a category attached, or 74.4%. Boston Scientific accounts for 60.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $33,352 and has fallen 89.2% since, to $3,595 in 2025.

$70,093in general payments, 2019–2025

Across 158 payments — averaging $443.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$42K
Medtronic$23K
AstraZeneca$2K
Abbott$2K
Philips North America LLC$162
Cardiva Medical, Inc.$142
plus $356 from 6 others

$5,950in research payments, 2019–2025

Across 8 payments — averaging $743.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Atricure, Inc.$6K

What the payments were for

Consulting fees$52,17574%
Speaking & faculty fees$1,5002%
Travel & lodging$11,08216%
Food & beverage$5,1467%
Education$1900%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	67	$42,445
Medtronic(2 entities)	49	$22,886
AstraZeneca	1	$2,400
Abbott	26	$1,702
Philips North America LLC	2	$162
Cardiva Medical, Inc.	2	$142
Impulse Dynamics (USA) Inc.	1	$134
Biosense Webster, Inc.	4	$71
Biotronik Inc.	1	$65
Edwards Lifesciences	2	$40
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$29
Shockwave Medical, Inc	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

RHYTHMIA$24,571
GENERAL - THERAPIES$9,703
CLINICAL TRIAL PRODUCT$4,025
ANDEXXA$2,400
GENERAL EP$1,119
Watchman$482
Micra$290
OPTIMIZER$268
AVEIR$172
(9520) IGT Devices Undivided$138
Cardiva VASCADE MVP VVCS 6-12F$124
TACTICATH ABLATION CATHETER, SENSOR ENABLED$123
ENSITE PRECISION$107
ENSITE$103
MitraClip System$100

How this compares

$70,093 in reported general payments places this provider in the 80th percentile of 90 clinical cardiac electrophysiology providers in Virginia.

See all clinical cardiac electrophysiology providers in Virginia →

Medicare billing

Part B allowed, 2024

$57,655

Medicare patients

542

Services billed

886

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	101	$80,777
Dofetilide	33	$2,998
Metoprolol Succinate	75	$1,331
Flecainide Acetate	37	$909
Hydralazine Hcl	12	$442
Rosuvastatin Calcium	14	$252
Carvedilol	35	$219
Diltiazem 24hr Er (Xr)Diltiazem Hcl	11	$204
Losartan Potassium	18	$174
Amiodarone Hcl	17	$133
Hydrochlorothiazide	13	$15

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Charlottesville

Oliver MonfrediCharlottesville$231K
Pamela MasonCharlottesville$130K
James MangrumCharlottesville$46K
John DimarcoCharlottesville$23K
George ProusiCharlottesville$16K
John FergusonCharlottesville$9K
Kenneth EllenbogenRichmond$360K
Brett AtwaterFairfax$319K
Peem LorvidhayaFredericksburg$230K
Erich KiehlNewport News$181K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →